Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Legend Biotech Corp
About LEGN
Legend Biotech Corporation is a global biopharmaceutical company. The Company is engaged in the discovery, development, manufacturing and commercialization of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), referred to as LCAR- B38M, is an autologous chimeric antigen receptor (CAR-T) cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in several hematologic malignancies, including multiple myeloma (MM). In addition to cilta-cel, the Company has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, small cell lung cancer, and non-small cell lung cancer. It is also engaged in developing an allogeneic gamma delta CAR-T product candidate and an allogeneic CAR-NK product candidate targeting BCMA for MM.
Find out what a historical investment in Legend Biotech Corp would be worth today using our LEGN stock calculator.
Market Capitalisation
$5.00B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
1.38M
High today
$28.27
Low today
$26.72
Open price
$27.04
52-week high
$45.30
52-week low
$16.24
Ready to start your investing journey with Stake?
Open an accountHow do I buy LEGN shares in Australia?
Buying LEGN shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Legend Biotech Corp in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in LEGN
What is the ticker symbol of Legend Biotech Corp?
The ticker symbol for Legend Biotech Corp is LEGN.
How much is one share of LEGN?
One share of LEGN is valued at $28.16 as of 21 May 2026.
What is the market capitalisation of Legend Biotech Corp LEGN?
As of 21 May 2026 Legend Biotech Corp has a market cap of $5.00B.
What is the 52-week high for Legend Biotech Corp stock?
The Legend Biotech Corp 52-week high stock price is $45.30.
What is the 52-week low for Legend Biotech Corp stock?
The Legend Biotech Corp 52-week low stock price is $16.24.
Can I buy LEGN shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy LEGN shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in LEGN on Stake
- Buy LEGN from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of LEGN from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
LEGN related stocks